IMC株式会社 代表取締役社長
梁 慧賢（リャン・ホイシェン）
| Company Name | IMC Inc. (IMC Co., Ltd.) |
|---|---|
| Head Office | 2F, MK Kojimachi Building, 4-2-1 Kojimachi, Chiyoda-ku, Tokyo 102-0083, Japan |
| Established | 2016 (Incorporated in 2017) |
| Capital | JPY 65 million |
| Certification | Certified Identity Guarantee Organization by the Ministry of Economy, Trade and Industry and the Ministry of Foreign Affairs (B-121) |
| Main Businesses |
|
| Group Locations | Japan, China (Hong Kong, Beijing, Guangzhou, Jilin) |
From initial consultations and medical interpretation to appointment coordination, telemedicine, in-person visit support, and post-return follow-up, we provide end-to-end, one-stop support.
We maintain official partnerships with top-tier medical institutions, including Tokyo Medical University Hospital, Juntendo University Hospital, and St. Luke’s International Hospital.
Serving clients and partners in more than 10 countries, with over 3,000 successful support cases.
In collaboration with regenerative medicine and immune cell research, we are developing and expanding the Tsubakigado (GOKIGENYOU) brand.
Copyright © 2025. All Right Reserved.
